Egyptian coronavirus vaccine to undergo clinical trials

Egyptian coronavirus vaccine to undergo clinical trials

CAIRO: The Egyptian Drug Authority (EDA) has approved the manufacture of the first doses of an Egyptian coronavirus vaccine, Covi Vax, according to local media. The Egyptian channel DMC show "Egypt Can" showed the first pictures of the Covi Vax packages amid plans to begin clinical trials on the vaccine. "Egypt is moving at a steady pace and is participating in producing a coronavirus vaccine," the show's host, Ahmed Fayek, said. "The Egyptian Drug Authority granted a factory a license to produce the first experimental samples (of the vaccine)," he added. Fayek said that Egypt will be the first country in the Middle East to manufacture a coronavirus vaccine with solely Egyptian efforts. "The study and research of the Egyptian coronavirus vaccine have been published in a specialized international scientific journal, as it has proven its effectiveness in laboratory experiments and experiments on animals," he added. Fayek said that the EDA had given approval to produce the first experimental batch. After obtaining approval for clinical trials, the vaccine will pass through three stages. The first will include a small number of people to ensure the safety of the vaccine on humans. The second will include 100 to 500 volunteers, while